PRECIGEN, INC. Gain (Loss) on Disposition of Assets
PRECIGEN, INC. (PGEN) reported Gain (Loss) on Disposition of Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-04
- PRECIGEN, INC. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00.
- PRECIGEN, INC. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- PRECIGEN, INC. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was -$14.00K.
- PRECIGEN, INC. gain (loss) on disposition of assets for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. gain (loss) on disposition of assets for fiscal 2025 was -$14.00K, a 800.00% decline from fiscal 2024.
- PRECIGEN, INC. gain (loss) on disposition of assets for fiscal 2024 was $2.00K, a 97.22% decline from fiscal 2023.
- PRECIGEN, INC. gain (loss) on disposition of assets for fiscal 2023 was $72.00K.
- PRECIGEN, INC. gain (loss) on disposition of assets for fiscal 2022 was -$421.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | -$14.00K derived: sum of 3 quarters · filed 2026-08-04 | -$14.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$14.00K derived: sum of 2 quarters · filed 2026-08-04 | -$14.00K 10-Q · filed 2025-11-13 | -$14.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$14.00K 10-Q · filed 2026-08-04 | -$14.00K derived: sum of 3 quarters · filed 2026-08-04 | -$15.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | -$1.00K derived: sum of 3 quarters · filed 2026-03-25 | -$1.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.00K derived: sum of 2 quarters · filed 2026-03-25 | -$1.00K derived: sum of 3 quarters · filed 2026-03-25 | $2.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.00K derived: sum of 2 quarters · filed 2025-11-13 | $2.00K 10-Q · filed 2025-11-13 | $6.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $3.00K 10-Q · filed 2025-08-12 | $7.00K derived: sum of 3 quarters · filed 2026-03-25 | $35.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-14 | $7.00K derived: sum of 2 quarters · filed 2026-03-25 | $35.00K derived: sum of 3 quarters · filed 2026-03-25 | $75.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $32.00K derived: sum of 2 quarters · filed 2026-03-25 | $72.00K derived: sum of 3 quarters · filed 2026-03-25 | $72.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $68.00K derived: sum of 2 quarters · filed 2024-11-14 | $68.00K 10-Q · filed 2024-11-14 | $68.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $40.00K 10-Q · filed 2024-08-14 | $40.00K derived: sum of 3 quarters · filed 2025-03-19 | -$21.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-19 | -$61.00K derived: sum of 3 quarters · filed 2025-03-19 | -$296.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$61.00K derived: sum of 2 quarters · filed 2025-03-19 | -$296.00K derived: sum of 3 quarters · filed 2025-03-19 | -$421.00K 10-K · filed 2025-03-19 |
| 2022-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$296.00K derived: sum of 2 quarters · filed 2023-11-09 | -$421.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$360.00K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$125.00K 10-Q · filed 2023-05-10 | |||
| 2021-09-30 | -$318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$432.00K derived: sum of 2 quarters · filed 2022-11-09 | -$89.00K 10-Q · filed 2022-11-09 | -$2.92M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $229.00K 10-Q · filed 2022-08-08 | -$2.61M derived: sum of 3 quarters · filed 2022-08-08 | -$3.22M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $343.00K 10-Q · filed 2022-05-09 | -$2.49M derived: sum of 2 quarters · filed 2022-05-09 | -$3.11M derived: sum of 3 quarters · filed 2022-05-09 | -$3.88M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$3.45M derived: sum of 2 quarters · filed 2021-11-08 | -$4.22M derived: sum of 3 quarters · filed 2021-11-08 | -$4.44M 10-K · filed 2021-03-01 |
| 2020-09-30 | -$615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$1.39M derived: sum of 2 quarters · filed 2021-11-08 | -$1.61M 10-Q · filed 2021-11-08 | -$2.80M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$774.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$991.00K 10-Q · filed 2021-08-09 | -$2.19M derived: sum of 3 quarters · filed 2021-08-09 | -$2.78M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$217.00K 10-Q · filed 2021-05-10 | -$1.41M derived: sum of 2 quarters · filed 2021-05-10 | -$2.00M derived: sum of 3 quarters · filed 2021-05-10 | -$2.79M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$1.78M derived: sum of 2 quarters · filed 2021-03-01 | -$2.58M derived: sum of 3 quarters · filed 2021-03-01 | -$3.07M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.38M derived: sum of 2 quarters · filed 2020-11-09 | -$1.88M 10-Q · filed 2020-11-09 | -$18.69M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$793.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.29M 10-Q · filed 2020-08-10 | -$18.10M derived: sum of 3 quarters · filed 2021-03-01 | -$16.63M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$493.00K 10-Q · filed 2020-05-11 | -$17.31M derived: sum of 2 quarters · filed 2021-03-01 | -$15.84M derived: sum of 3 quarters · filed 2021-03-01 | -$21.11M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$16.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$15.34M derived: sum of 2 quarters · filed 2021-03-01 | -$20.61M derived: sum of 3 quarters · filed 2021-03-01 | -$20.93M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$3.79M derived: sum of 2 quarters · filed 2019-11-12 | -$4.11M 10-Q · filed 2019-11-12 | -$5.92M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$5.58M 10-Q · filed 2019-08-09 | -$7.40M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$316.00K 10-Q · filed 2019-05-09 | -$2.13M derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$3.12M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$1.31M 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | -$666.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |